Association between MC4R rs17782313 polymorphism and overeating behaviors

Z Yilmaz¹, C Davis², N J Loxton³, A S Kaplan⁴, R D Levitan⁵, J C Carter⁶, J L Kennedy⁷

Affiliations

¹ 1] Department of Psychiatry, Center of Excellence for Eating Disorders, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA [2] Clinical Research Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
² 1] Clinical Research Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada [2] Kinesiology and Health Sciences, York University, Toronto, Ontario, Canada [3] Eating Disorders Program, Toronto General Hospital, Toronto, Ontario, Canada.
³ School of Psychology, The University of Queensland, Brisbane, Queensland, Australia.
⁴ 1] Clinical Research Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada [2] Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada [3] Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
⁵ 1] Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada [2] Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada [3] Mood and Anxiety Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
⁶ Department of Psychology, Memorial University, St. John's, Newfoundland, Canada.
⁷ 1] Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada [2] Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada [3] Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

PMID: 24827639
PMCID: PMC4232480
DOI: 10.1038/ijo.2014.79

Association between MC4R rs17782313 polymorphism and overeating behaviors

Z Yilmaz et al. Int J Obes (Lond). 2015 Jan.

. 2015 Jan;39(1):114-20.

doi: 10.1038/ijo.2014.79. Epub 2014 May 14.

Authors

Z Yilmaz¹, C Davis², N J Loxton³, A S Kaplan⁴, R D Levitan⁵, J C Carter⁶, J L Kennedy⁷

Affiliations

¹ 1] Department of Psychiatry, Center of Excellence for Eating Disorders, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA [2] Clinical Research Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
² 1] Clinical Research Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada [2] Kinesiology and Health Sciences, York University, Toronto, Ontario, Canada [3] Eating Disorders Program, Toronto General Hospital, Toronto, Ontario, Canada.
³ School of Psychology, The University of Queensland, Brisbane, Queensland, Australia.
⁴ 1] Clinical Research Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada [2] Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada [3] Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
⁵ 1] Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada [2] Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada [3] Mood and Anxiety Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
⁶ Department of Psychology, Memorial University, St. John's, Newfoundland, Canada.
⁷ 1] Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada [2] Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada [3] Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

PMID: 24827639
PMCID: PMC4232480
DOI: 10.1038/ijo.2014.79

Abstract

Background/objectives: Melanocortins have a crucial role in appetite and weight regulation. Although the melanocortin 4 receptor (MC4R) gene has been repeatedly linked to obesity and antipsychotic-induced weight gain, the mechanism behind how it leads to this effect in still undetermined. The goal of this study was to conduct an in-depth and sophisticated analysis of MC4R polymorphisms, body mass index (BMI), eating behavior and depressed mood.

Subjects/methods: We genotyped 328 individuals of European ancestry on the following MC4R markers based on the relevant literature on obesity and antipsychotic-induced weight gain: rs571312, rs17782313, rs489693, rs11872992, and rs8087522. Height and weight were measured, and information on depressed mood and overeating behaviors was obtained during the in-person assessment.

Results: BMI was associated with rs17782313 C allele; however, this finding did not survive correction for multiple testing (P = 0.018). Although rs17782313 was significantly associated with depressed mood and overeating behaviors, tests of indirect effects indicated that emotional eating and food cravings, rather than depressed mood, uniquely accounted for the effect of this marker and BMI (n = 152).

Conclusions: To our knowledge, this is the first study to investigate the link between MC4R rs17782313, mood and overeating behavior, as well as to demonstrate possible mechanisms behind MC4R's influence on body weight. If replicated in a larger sample, these results may have important clinical implications, including potential for the use of MC4R agonists in the treatment of obesity and disordered eating.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Dr. Kennedy has received honoraria from Eli Lilly and Roche, whereas Dr. Levitan has received honorarium from Astra-Zeneca. Other authors have no financial interests to disclose.

Figures

**Figure 1**
Multiple mediation model of the relationship between MC4R, depressed mood, emotional eating/cravings, and BMI. *Note.* Standardized coefficients are presented and tested for significance with 95% confidence intervals calculated using the bias-corrected bootstrap method (5000 samples). a = standardized IV to Med coefficient, b = standardized Med to DV coefficient, c = standardized total effect (IV to DV), c′ = standardized direct effect. Subscripts refer to specific indirect paths. * p < .05 ** p < .01 *** p <.001

**Figure 2**
Linkage disequilibrium plot for the five *MC4R* markers.

See this image and copyright information in PMC

References

1. WHO Global Infobase. BMI/overweight/obesity Prevalence. World Health Organization; United States of America: 2006. Available from http://infobase.who.int.
1. Fuemmeler BF, Agurs-Collins TD, McClernon FJ, Kollins SH, Kail ME, Bergen AW, et al. Genes implicated in serotonergic and dopaminergic functioning predict BMI categories. Obesity (Silver Spring) 2008;16:348–355. - PMC - PubMed
1. Need AC, Ahmadi KR, Spector TD, Goldstein DB. Obesity is associated with genetic variants that alter dopamine availability. Ann Hum Genet. 2006;70(Pt 3):293–303. - PubMed
1. Grayson BE, Seeley RJ. Deconstructing obesity: the face of fatness before and after the discovery of leptin. Diabetologia. 2012;55:3–6. - PubMed
1. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997;88:131–141. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Association between MC4R rs17782313 polymorphism and overeating behaviors

Affiliations

Association between MC4R rs17782313 polymorphism and overeating behaviors

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical